FUJIKAWA RAYMOND 4
4 · ORTHOFIX INTERNATIONAL N V · Filed Jun 21, 2018
Insider Transaction Report
Form 4
FUJIKAWA RAYMOND
President Spine Fixation
Transactions
- Sale
Common Stock
2018-06-20$60.16/sh−28,047$1,687,369→ 17,055 total - Exercise/Conversion
Common Stock
2018-06-20$21.78/sh+8,750$190,575→ 45,102 total - Exercise/Conversion
Common Stock
2018-06-20$22.75/sh+10,000$227,500→ 36,352 total - Sale
Common Stock
2018-06-20$60.49/sh−4,196$253,833→ 12,859 total - Exercise/Conversion
Stock Option (right to buy)
2018-06-20−10,000→ 0 totalExercise: $22.75From: 2017-08-01Exp: 2023-08-01→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-06-20−8,750→ 0 totalExercise: $21.78From: 2017-09-26Exp: 2023-09-26→ Common Stock (8,750 underlying)
Footnotes (4)
- [F1]The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
- [F2]The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.42 to $60.40, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.42 to $60.61, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.